Three-Dimensional Multi-Frequency Shear Wave Absolute Vibro-Elastography (3D S-WAVE) With a Matrix Array Transducer: Implementation and Preliminary In Vivo Study of the Liver

Analysis wave speed of optic nerve and optic nerve head for assessing normal tension glaucoma by using vibro-elastography technique

BACKGROUND

This research aims to evaluate wave speed and viscoelasticity of ocular tissues including the optic nerve and optic nerve head of human eyes between normal tension glaucoma patients and healthy controls by using vibro-elastography techniques.

METHODS

Participants included 12 patients and 12 controls. Wave speed was measured at the optic nerve and optic nerve head in each subject and viscoelasticity was estimated by using Voigt model. Wave speed and viscoelasticity of the optic nerve and optic nerve head were compared between patients and controls by linear mixed models via a restricted maximum likelihood method. The correlation between intraocular pressure and wave speed, elasticity, and viscosity of patients was performed using the Pearson correlation coefficient.

FINDINGS

Significant differences in wave speed (p < 0.0005), elasticity (p = 0.0001) and viscosity p < 0.0001) between patients and controls at the optic nerve head. There was a moderate negative correlation (r = -0.50, p < 0.05) between wave speed and elasticity and intraocular pressure at the optic nerve of patients but no correlation (p > 0.05) between wave speed, elasticity, and viscosity and intraocular pressure at the optic nerve head of patients. No significant difference and correlation among wave speed, elasticity, and viscosity vs. intraocular pressure of the control group at the optic nerve and optic nerve head.

INTERPRETATION

Ultrasound vibro-elastography is useful for noninvasive measurement of viscoelasticity of ocular structures. The glaucoma patient is associated with biomechanical property changes in the optic nerve and optic nerve head, suggesting another way to assess glaucoma focusing on the optic nerve and optic nerve head.

Four-Dimensional (4D) Ultrasound Shear Wave Elastography Using Sequential Excitation

OBJECTIVE

Current shear wave elastography methods primarily focus on 2D imaging. To explore mechanical properties of biological tissues in 3D, a four-dimensional (4D, x, y, z, t) ultrasound shear wave elastography is required. However, 4D ultrasound shear wave elastography is still challenging due to the limitation of the hardware of standard ultrasound acquisition systems. In this study, we introduce a novel method to achieve 4D shear wave elastography, named sequential-based excitation shear wave elastography (SE-SWE). This method can achieve 4D elastography implemented by a 1024-element 2D array with a standard ultrasound 256-channel system.

METHODS

The SE-SWE method employs sequential excitation to generate shear waves, and utilizes a 2D array, dividing it into four sub-sections, to capture shear waves across multiple planes. This process involves sequentially exciting each sub-section to capture shear waves, followed by compounding the acquired data from these subsections.

RESULTS

The phantom studies showed strong concordance between the shear wave speeds (SWS) measured by SE-SWE and expected values, confirming the accuracy of this method and potential to differentiate tissues by stiffness. In ex vivo chicken breast experiments, SE-SWE effectively distinguished between orientations relative to muscle fibers, highlighting its ability to capture the anisotropic properties of tissues.

CONCLUSION

The SE-SWE method advances shear wave elastography significantly by using a 2D array divided into four subsections and sequential excitation, achieving high-resolution volumetric imaging at 1.6mm resolution.

SIGNIFICANCE

The SE-SWE method offers a straightforward and effective approach for 3D shear volume imaging of tissue biological properties.

Validation of Volumetric Multifrequency Shear Wave Vibro-Elastography With Matrix Array Transducer for the In Vivo Liver

Three-dimensional shear wave absolute vibro-elastography (S-WAVE) is a steady-state, volumetric elastography imaging technique similar to magnetic resonance elastography (MRE), with the additional advantage of multifrequency imaging and a significantly shorter examination time. We present a novel ultrasound matrix array implementation of S-WAVE for high-volume refresh rate acquisition. This new imaging setup is equipped with real-time shear wave monitoring for an improved data collection workflow and image quality. The image processing and elasticity reconstruction pipeline is tailored for high body mass index (BMI) subjects. We characterized this system with tissue phantoms and a human study cohort composed of 7 healthy volunteers and 25 patients with nonalcoholic fatty liver disease. The validation results show that S-WAVE can maintain a high agreement with the liver tissue stiffness measurements obtained with both the 2-D and 3-D MRE techniques, with an average cross correlation >93% and an average , which outperforms the conventional transient elasticity technique. Our findings show that the matrix array-based 3-D S-WAVE is a suitable volumetric elastography imaging solution for delivering a similar assessment of liver fibrosis as MRE in a more accessible, flexible, and cost-effective way.

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Liver fibrosis is a reparative response triggered by liver injury. Non‐invasive assessment and staging of liver fibrosis in patients with chronic liver disease are of paramount importance, as treatment strategies and prognoses depend significantly on the degree of fibrosis. Although liver fibrosis has traditionally been staged through invasive liver biopsy, this method is prone to sampling errors, particularly when biopsy sizes are inadequate. Consequently, there is an urgent clinical need for an alternative to biopsy, one that ensures precise, sensitive, and non‐invasive diagnosis and staging of liver fibrosis. Non‐invasive imaging assessments have assumed a pivotal role in clinical practice, enjoying growing popularity and acceptance due to their potential for diagnosing, staging, and monitoring liver fibrosis. In this comprehensive review, we first delved into the current landscape of non‐invasive imaging technologies, assessing their accuracy and the transformative impact they have had on the diagnosis and management of liver fibrosis in both clinical practice and animal models. Additionally, we provided an in‐depth exploration of recent advancements in ultrasound imaging, computed tomography imaging, magnetic resonance imaging, nuclear medicine imaging, radiomics, and artificial intelligence within the field of liver fibrosis research. We summarized the key concepts, advantages, limitations, and diagnostic performance of each technique. Finally, we discussed the challenges associated with clinical implementation and offer our perspective on advancing the field, hoping to provide alternative directions for the future research.

Phantoms for Quantitative Body MRI: a review and discussion of the phantom value

In this paper, we review the value of phantoms for body MRI in the context of their uses for quantitative MRI methods research, clinical trials, and clinical imaging. Certain uses of phantoms are common throughout the body MRI community, including measuring bias, assessing reproducibility, and training. In addition to these uses, phantoms in body MRI methods research are used for novel methods development and the design of motion compensation and mitigation techniques. For clinical trials, phantoms are an essential part of quality management strategies, facilitating the conduct of ethically sound, reliable, and regulatorily compliant clinical research of both novel MRI methods and therapeutic agents. In the clinic, phantoms are used for development of protocols, mitigation of cost, quality control, and radiotherapy. We briefly review phantoms developed for quantitative body MRI, and finally, we review open questions regarding the most effective use of a phantom for body MRI.

Multi-Frequency 3D Shear Wave Absolute Vibro-Elastography (S-WAVE) System for the Prostate

This article describes a novel system for quantitative and volumetric measurement of tissue elasticity in the prostate using simultaneous multi-frequency tissue excitation. Elasticity is computed by using a local frequency estimator to measure the three-dimensional local wavelengths of steady-state shear waves within the prostate gland. The shear wave is created using a mechanical voice coil shaker which transmits simultaneous multi-frequency vibrations transperineally. Radio frequency data is streamed directly from a BK Medical 8848 transrectal ultrasound transducer to an external computer where tissue displacement due to the excitation is measured using a speckle tracking algorithm. Bandpass sampling is used that eliminates the need for an ultra-fast frame rate to track the tissue motion and allows for accurate reconstruction at a sampling frequency that is below the Nyquist rate. A roll motor with computer control is used to rotate the transducer and obtain 3D data. Two commercially available phantoms were used to validate both the accuracy of the elasticity measurements as well as the functional feasibility of using the system for in vivo prostate imaging. The phantom measurements were compared with 3D Magnetic Resonance Elastography (MRE), where a high correlation of 96% was achieved. In addition, the system has been used in two separate clinical studies as a method for cancer identification. Qualitative and quantitative results of 11 patients from these clinical studies are presented here. Furthermore, an AUC of 0.87±0.12 was achieved for malignant vs. benign classification using a binary support vector machine classifier trained with data from the latest clinical study with leave one patient out cross-validation.

Possible depth-resolved reconstruction of shear moduli in the cornea following collagen crosslinking (CXL) with optical coherence tomography and elastography

Corneal collagen crosslinking (CXL) is commonly used to prevent or treat keratoconus. Although changes in corneal stiffness induced by CXL surgery can be monitored with non-contact dynamic optical coherence elastography (OCE) by tracking mechanical wave propagation, depth dependent changes are still unclear if the cornea is not crosslinked through the whole depth. Here, phase-decorrelation measurements on optical coherence tomography (OCT) structural images are combined with acoustic micro-tapping (AµT) OCE to explore possible reconstruction of depth-dependent stiffness within crosslinked corneas in an ex vivo human cornea sample. Experimental OCT images are analyzed to define the penetration depth of CXL into the cornea. In a representative ex vivo human cornea sample, crosslinking depth varied from ∼100 µm in the periphery to ∼150 µm in the cornea center and exhibited a sharp in-depth transition between crosslinked and untreated areas. This information was used in an analytical two-layer guided wave propagation model to quantify the stiffness of the treated layer. We also discuss how the elastic moduli of partially CXL-treated cornea layers reflect the effective engineering stiffness of the entire cornea to properly quantify corneal deformation.

3-D Ultrafast Shear Wave Absolute Vibro-Elastography Using a Matrix Array Transducer

Real-time ultrasound imaging plays an important role in ultrasound-guided interventions. The 3-D imaging provides more spatial information compared to conventional 2-D frames by considering the volumes of data. One of the main bottlenecks of 3-D imaging is the long data acquisition time, which reduces practicality and can introduce artifacts from unwanted patient or sonographer motion. This article introduces the first shear wave absolute vibro-elastography (S-WAVE) method with real-time volumetric acquisition using a matrix array transducer. In S-WAVE, an external vibration source generates mechanical vibrations inside the tissue. The tissue motion is then estimated and used in solving a wave equation inverse problem to provide the tissue elasticity. A matrix array transducer is used with a Verasonics ultrasound machine and a frame rate of 2000 volumes/s to acquire 100 radio frequency (RF) volumes in 0.05 s. Using plane wave (PW) and compounded diverging wave (CDW) imaging methods, we estimate axial, lateral, and elevational displacements over 3-D volumes. The curl of the displacements is used with local frequency estimation to estimate elasticity in the acquired volumes. Ultrafast acquisition extends substantially the possible S-WAVE excitation frequency range, now up to 800 Hz, enabling new tissue modeling and characterization. The method was validated on three homogeneous liver fibrosis phantoms and on four different inclusions within a heterogeneous phantom. The homogeneous phantom results show less than 8% (PW) and 5% (CDW) difference between the manufacturer values and the corresponding estimated values over a frequency range of 80-800 Hz. The estimated elasticity values for the heterogeneous phantom at 400-Hz excitation frequency show the average errors of 9% (PW) and 6% (CDW) compared to the provided average values by magnetic resonance elastography (MRE). Furthermore, both imaging methods were able to detect the inclusions within the elasticity volumes. An ex vivo study on a bovine liver sample shows less than 11% (PW) and 9% (CDW) difference between the estimated elasticity ranges by the proposed method and the elasticity ranges provided by MRE and acoustic radiation force impulse (ARFI).

3-D Transducer Mounted Shear Wave Absolute Vibro-Elastography: Proof of Concept

Quantitative tissue stiffness characterization using ultrasound (US) has been shown to improve prostate cancer (PCa) detection in multiple studies. Shear wave absolute vibro-elastography (SWAVE) allows quantitative and volumetric assessment of tissue stiffness using external multifrequency excitation. This article presents a proof of concept of a first-of-a-kind 3-D hand-operated endorectal SWAVE system designed to be used during systematic prostate biopsy. The system is developed with a clinical US machine, requiring only an external exciter that can be mounted directly to the transducer. Subsector acquisition of radio frequency (RF) data allows imaging of shear waves with a high effective frame rate (up to 250 Hz). The system was characterized using eight different quality assurance phantoms. Due to the invasive nature of prostate imaging, at this early stage of development, validation of in vivo human tissue was instead carried out by intercostally scanning the livers of n = 7 healthy volunteers. The results are compared with 3-D magnetic resonance elastography (MRE) and an existing 3-D SWAVE system with a matrix array transducer (M-SWAVE). High correlations were found with MRE (99% in phantoms, 94% in liver data) and with M-SWAVE (99% in phantoms, 98% in liver data).

Doppler and Pair-Wise Optical Flow Constrained 3D Motion Compensation for 3D Ultrasound Imaging

Volumetric (3D) ultrasound imaging using a 2D matrix array probe is increasingly developed for various clinical procedures. However, 3D ultrasound imaging suffers from motion artifacts due to tissue motions and a relatively low frame rate. Current Doppler-based motion compensation (MoCo) methods only allow 1D compensation in the in-range dimension. In this work, we propose a new 3D-MoCo framework that combines 3D velocity field estimation and a two-step compensation strategy for 3D diverging wave compounding imaging. Specifically, our framework explores two constraints of a round-trip scan sequence of 3D diverging waves, i.e., Doppler and pair-wise optical flow, to formulate the estimation of the 3D velocity fields as a global optimization problem, which is further regularized by the divergence-free and first-order smoothness. The two-step compensation strategy is to first compensate for the 1D displacements in the in-range dimension and then the 2D displacements in the two mutually orthogonal cross-range dimensions. Systematical in-silico experiments were conducted to validate the effectiveness of our proposed 3D-MoCo method. The results demonstrate that our 3D-MoCo method achieves higher image contrast, higher structural similarity, and better speckle patterns than the corresponding 1D-MoCo method. Particularly, the 2D cross-range compensation is effective for fully recovering image quality.

Phase-regularized and displacement-regularized compressed sensing for fast magnetic resonance elastography

Liver magnetic resonance elastography (MRE) is a noninvasive stiffness measurement technique that captures the tissue displacement in the phase of the signal. To limit the scanning time to a single breath-hold, liver MRE usually involves advanced readout techniques such as simultaneous multislice (SMS) or multishot methods. Furthermore, all these readout techniques require additional in-plane acceleration using either parallel imaging capabilities, such as sensitivity encoding (SENSE), or k -space undersampling, such as compressed sensing (CS). However, these methods apply a single regularization function on the complex image. This study aims to design and evaluate methods that use separate regularization on the magnitude and phase of MRE to exploit their distinct spatiotemporal characteristics. Specifically, we introduce two compressed sensing methods. The first method, termed phase-regularized compressed sensing (PRCS), applies a two-dimensional total variation (TV) prior to the magnitude and two-dimensional wavelet regularization to the phase. The second method, termed displacement-regularized compressed sensing (DRCS), exploits the spatiotemporal redundancy using 3D total variation on the magnitude. Additionally, DRCS includes a displacement fitting function to apply wavelet regularization to the displacement phasor. Both DRCS and PRCS were evaluated with different levels of compression factors in three datasets: an in silico abdomen dataset, an in vitro tissue-mimicking phantom, and an in vivo liver dataset. The reconstructed images were compared with the full sampled reconstruction, zero-filling reconstruction, wavelet-regularized compressed sensing, and a low rank plus sparse reconstruction. The metrics used for quantitative evaluation were the structural similarity index (SSIM) of magnitude (M-SSIM), displacement (D-SSIM), and shear modulus (S-SSIM), and mean shear modulus. Results from highly undersampled in silico and in vitro datasets demonstrate that the DRCS method provides higher reconstruction quality than the conventional compressed sensing method for a wide range of stiffness values. Notably, DRCS provides 24% and 22% increase in D-SSIM compared with CS for the in silico and in vitro datasets, respectively. Comparison with liver stiffness measured from full sampled data and highly undersampled data (CR=4) demonstrates that the DRCS method provided the strongest correlation ( R 2 =0.95), second-lowest mean bias (-0.18 kPa, lowest for CS with -0.16 kPa), and lowest coefficient of variation (CV=3.6%). Our results demonstrate the potential of using DRCS to improve the reconstruction quality of accelerated MRE.

Evaluating Variability of Commercial Liver Fibrosis Elastography Phantoms

OBJECTIVE

Liver fibrosis has been found to increase the mechanical stiffness of the liver. To mimic different stages of liver fibrosis, commercially available phantoms (Model 039, CIRS, Inc.) have been produced for clinical quality assurance and research purposes. The purpose of this study was to investigate the mechanical property variability of the phantoms in two lots of CIRS Model 039 phantoms.

METHODS

Each lot consisted of phantoms of four stiffness types, and there were 8-10 phantoms of each type. Shear wave elastography measurements were conducted on each phantom at 10 different angles. Group velocity measurements and phase velocity curves were calculated for every SWE acquisition. Multilevel functional principal component analysis (MFPCA) was performed on phase velocity data, which decomposes each phase velocity curve into the sum of eigenfunctions of two levels. The variance of the component scores of levels 1 and 2 were used to represent inter-phantom and intra-phantom variability, respectively. The 95% confidence intervals of phase velocity in a phantom type were calculated to reflect curve variability.

DISCUSSION

The standard deviations of the group velocity for phantoms of any type were less than 0.04 and 0.02 m/s for lots 1 and 2, respectively. For both lots, in every type, the phase velocity curves of most individual phantoms fall within the 95% confidence interval.

CONCLUSION

MFPCA is an effective tool for analyzing the inter- and intra-phantom variability of phase velocity curves. Given the known variability of a fully tested lot, estimation of the variability of a new lot can be performed with a reduced number of phantoms tested.

Robotically controlled three-dimensional micro-ultrasound for prostate biopsy guidance

PURPOSE

Prostate imaging to guide biopsy remains unsatisfactory, with current solutions suffering from high complexity and poor accuracy and reliability. One novel entrant into this field is micro-ultrasound (microUS), which uses a high-frequency imaging probe to achieve very high spatial resolution, and achieves prostate cancer detection rates equivalent to multiparametric magnetic resonance imaging (mpMRI). However, the ExactVu transrectal microUS probe has a unique geometry that makes it challenging to acquire controlled, repeatable three-dimensional (3D) transrectal ultrasound (TRUS) volumes. We describe the design, fabrication, and validation of a 3D acquisition system that allows for the accurate use of the ExactVu microUS device for volumetric prostate imaging.

METHODS

The design uses a motorized, computer-controlled brachytherapy stepper to rotate the ExactVu transducer about its axis. We perform geometric validation using a phantom with known dimensions and compare performance with magnetic resonance imaging (MRI) using a commercial quality assurance anthropomorphic prostate phantom.

RESULTS

Our geometric validation shows accuracy of 1 mm or less in all three directions, and images of an anthropomorphic phantom qualitatively match those acquired using MRI and show good agreement quantitatively.

CONCLUSION

We describe the first system to acquire robotically controlled 3D microUS images using the ExactVu microUS system. The reconstructed 3D microUS images are accurate, which will allow for future applications of the ExactVu microUS system in prostate specimen and in vivo imaging.

SWAVE 2.0 Imaging of Placental Elasticity and Viscosity: Potential Biomarkers for Placenta-Mediated Disease Detection

Pregnancy complications such as pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are associated with structural and functional changes in the placenta. Different elastography techniques with an ability to assess the mechanical properties of tissue can identify and monitor the pathological state of the placenta. Currently available elastography techniques have been used with promising results to detect placenta abnormalities; however, limitations include inadequate measurement depth and safety concerns from high negative pressure pulses. Previously, we described a shear wave absolute vibro-elastography (SWAVE) method by applying external low-frequency mechanical vibrations to generate shear waves and studied 61 post-delivery clinically normal placentas to explore the feasibility of SWAVE for placental assessment and establish a measurement baseline. This next phase of the study, namely, SWAVE 2.0, improves the previous system and elasticity reconstruction by incorporating a multi-frequency acquisition system and using a 3-D local frequency estimation (LFE) method. Compared with its 2-D counterpart, the proposed system using 3-D LFE was found to reduce the bias and variance in elasticity measurements in tissue-mimicking phantoms. In the aim of investigating the potential of improved SWAVE 2.0 measurements to identify placental abnormalities, we studied 46 post-delivery placentas, including 26 diseased (16 IUGR and 10 PE) and 20 normal control placentas. By use of a 3.33-MHz motorized curved-array transducer, multi-frequency (80,100 and 120 Hz) elasticity measures were obtained with 3-D LFE, and both IUGR (15.30 ± 2.96 kPa, p = 3.35e^-5) and PE (12.33 ± 4.88 kPa, p = 0.017) placentas were found to be significantly stiffer compared with the control placentas (8.32 ± 3.67 kPa). A linear discriminant analysis (LDA) classifier was able to classify between healthy and diseased placentas with a sensitivity, specificity and accuracy of 87%, 78% and 83% and an area under the receiver operating curve of 0.90 (95% confidence interval: 0.8-0.99). Further, the pregnancy outcome in terms of neonatal intensive care unit admission was predicted with a sensitivity, specificity and accuracy of 70%, 71%, 71%, respectively, and area under the receiver operating curve of 0.78 (confidence interval: 0.62-0.93). A viscoelastic characterization of placentas using a fractional rheological model revealed that the viscosity measures in terms of viscosity parameter n were significantly higher in IUGR (2.3 ± 0.21) and PE (2.11 ± 0.52) placentas than in normal placentas (1.45 ± 0.65). This work illustrates the potential relevance of elasticity and viscosity imaging using SWAVE 2.0 as a non-invasive technology for detection of placental abnormalities and the prediction of pregnancy outcomes.

Preclinical Three-Dimensional Vibrational Shear Wave Elastography for Mapping of Tumour Biomechanical Properties In Vivo

Preclinical investigation of the biomechanical properties of tissues and their treatment-induced changes are essential to support drug-discovery, clinical translation of biomarkers of treatment response, and studies of mechanobiology. Here we describe the first use of preclinical 3D elastography to map the shear wave speed (cs), which is related to tissue stiffness, in vivo and demonstrate the ability of our novel 3D vibrational shear wave elastography (3D-VSWE) system to detect tumour response to a therapeutic challenge. We investigate the use of one or two vibrational sources at vibrational frequencies of 700, 1000 and 1200 Hz. The within-subject coefficients of variation of our system were found to be excellent for 700 and 1000 Hz and 5.4 and 6.2%, respectively. The relative change in cs measured with our 3D-VSWE upon treatment with an anti-vascular therapy ZD6126 in two tumour xenografts reflected changes in tumour necrosis. U-87 MG drug vs vehicle: Δcs = −24.7 ± 2.5 % vs 7.5 ± 7.1%, (p = 0.002) and MDA-MB-231 drug vs vehicle: Δcs = −12.3 ± 2.7 % vs 4.5 ± 4.7%, (p = 0.02). Our system enables rapid (<5 min were required for a scan length of 15 mm and three vibrational frequencies) 3D mapping of quantitative tumour viscoelastic properties in vivo, allowing exploration of regional heterogeneity within tumours and speedy recovery of animals from anaesthesia so that longitudinal studies (e.g., during tumour growth or following treatment) may be conducted frequently.

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

OBJECTIVE

To provide evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.

METHODS

The American Association of Clinical Endocrinology conducted literature searches for relevant articles published from January 1, 2010, to November 15, 2021. A task force of medical experts developed evidence-based guideline recommendations based on a review of clinical evidence, expertise, and informal consensus, according to established American Association of Clinical Endocrinology protocol for guideline development.

RECOMMENDATION SUMMARY

This guideline includes 34 evidence-based clinical practice recommendations for the diagnosis and management of persons with NAFLD and/or NASH and contains 385 citations that inform the evidence base.

CONCLUSION

NAFLD is a major public health problem that will only worsen in the future, as it is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Given this link, endocrinologists and primary care physicians are in an ideal position to identify persons at risk on to prevent the development of cirrhosis and comorbidities. While no U.S. Food and Drug Administration-approved medications to treat NAFLD are currently available, management can include lifestyle changes that promote an energy deficit leading to weight loss; consideration of weight loss medications, particularly glucagon-like peptide-1 receptor agonists; and bariatric surgery, for persons who have obesity, as well as some diabetes medications, such as pioglitazone and glucagon-like peptide-1 receptor agonists, for those with type 2 diabetes mellitus and NASH. Management should also promote cardiometabolic health and reduce the increased cardiovascular risk associated with this complex disease.

Hadamard-Encoded Synthetic Transmit Aperture Imaging for Improved Lateral Motion Estimation in Ultrasound Elastography

Lateral motion estimation has been a challenge in ultrasound elastography mainly due to the low resolution, low sampling frequency, and lack of phase information in the lateral direction. Synthetic transmit aperture (STA) can achieve high resolution due to two-way focusing and can beamform high-density image lines for improved lateral motion estimation with the disadvantages of low signal-to-noise ratio (SNR) and limited penetration depth. In this study, Hadamard-encoded STA (Hadamard-STA) is proposed for the improvement of lateral motion estimation in elastography, and it is compared with STA and conventional focused wave (CFW) imaging. Simulations, phantom, and in vivo experiments were conducted to make the comparison. The normalized root mean square error (NRMSE) and the contrast-to-noise ratio (CNR) were calculated as the evaluation criteria in the simulations. The results show that, at a noise level of -10 dB and an applied strain of -1% (compression), Hadamard-STA decreases the NRMSEs of lateral displacements by 46.92% and 35.35%, decreases the NRMSEs of lateral strains by 52.34% and 39.75%, and increases the CNRs by 9.70 and 9.75 dB compared with STA and CFW, respectively. In the phantom experiments performed on a heterogeneous tissue-mimicking phantom, the sum of squared differences (SSD) between the reference and the motion-compensated RF data, and the CNR were calculated as the evaluation criteria. At an applied strain of -1.80%, Hadamard-STA is found to decrease the SSDs by 20.91% and 30.99% and increase the CNRs by 14.15 and 24.66 dB compared with STA and CFW, respectively. In the experiments performed on a breast phantom, Hadamard-STA achieves better visualization of the breast inclusion with a clearer boundary between the inclusion and the background than STA and CFW. The in vivo experiments were performed on a patient with a breast tumor, and the tumor could also be better visualized with a more homogeneous background in the strain image obtained by Hadamard-STA than by STA and CFW. These results demonstrate that Hadamard-STA achieves a substantial improvement in lateral motion estimation and maybe a competitive method for quasi-static elastography.